Wolverine Asset Management LLC Invests $2.47 Million in Kenvue Inc. $KVUE

Wolverine Asset Management LLC acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 142,878 shares of the company’s stock, valued at approximately $2,465,000.

Several other large investors also recently modified their holdings of the company. Winslow Asset Management Inc. increased its position in shares of Kenvue by 3.6% during the fourth quarter. Winslow Asset Management Inc. now owns 178,181 shares of the company’s stock worth $3,074,000 after buying an additional 6,231 shares during the period. WJ Financial Advisors LLC increased its position in shares of Kenvue by 33.1% during the fourth quarter. WJ Financial Advisors LLC now owns 28,591 shares of the company’s stock worth $493,000 after buying an additional 7,116 shares during the period. Caisse Des Depots ET Consignations increased its position in shares of Kenvue by 31.4% during the fourth quarter. Caisse Des Depots ET Consignations now owns 318,100 shares of the company’s stock worth $5,487,000 after buying an additional 76,015 shares during the period. PFA Pension Forsikringsaktieselskab acquired a new stake in shares of Kenvue during the fourth quarter worth $16,364,000. Finally, Fifth Third Bancorp increased its position in shares of Kenvue by 17.8% during the fourth quarter. Fifth Third Bancorp now owns 225,399 shares of the company’s stock worth $3,888,000 after buying an additional 34,099 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

KVUE has been the subject of several recent analyst reports. Citigroup decreased their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Barclays decreased their price objective on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Argus upgraded shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a report on Wednesday, April 8th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Trading Down 1.6%

NYSE:KVUE opened at $17.15 on Tuesday. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $32.92 billion, a price-to-earnings ratio of 22.27, a PEG ratio of 3.96 and a beta of 0.55. The firm has a fifty day simple moving average of $17.72 and a two-hundred day simple moving average of $17.19. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period last year, the company posted $0.26 earnings per share. Analysts expect that Kenvue Inc. will post 1.1 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date is Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.